For the Inventor, By the Inventor

Enter assignee name

Walkersville, MD, United States of America

Lonza Walkersville, Inc.

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 7.7

CIPO Patents = 5

EPO Patents = 7

Trademarks = 58

Forward Citations = 94

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Eytan Abraham (10 out of 18 patents)

Yaling Shi (7 out of 22 patents)

Erika McAfee (6 out of 6 patents)

4. Samatha Bandapalle (6 out of 6 patents)

5. Joseph O'Connor (6 out of 6 patents)

6. Anandita Seth (6 out of 8 patents)

7. Kelly Purpura (5 out of 5 patents)

8. Nuala Trainor (5 out of 6 patents)

9. Timothy Smith (5 out of 10 patents)

10. Bingnan Gu (5 out of 6 patents)

11. Young Shin (5 out of 5 patents)

12. Ann Siehoff (4 out of 4 patents)

13. Timo Gleissner (4 out of 16 patents)

14. Matthew Hewitt (4 out of 4 patents)

15. Candice Stumbaugh (3 out of 4 patents)

Core Competencies:

Cell Concentration

Automated Bioreactors

Viral Vectors

Endotoxin Detection

Lentiviral Vector

Quality Control

Cell Culture

Synthetic Transcription Factors

Polymeric Carriers

Therapeutic Cells

Human Pluripotent Stem Cells

Collagen Degradation

26 patents: Sort by Forward Citations

1. 12606792 - Cell concentration methods and devices for use in automated bioreactors (2026-04-21),

2. 12529074 - ADENO-ASSOCIATED VIRUS (AAV) PRODUCER CELL LINE AND RELATED METHODS (2026-01-20),

3. 12398404 - Methods and constructs for transient production of lentiviral vector (2025-08-26),

4. 12391960 - Methods and constructs for production of lentiviral vector (2025-08-19),

5. 12359241 - Coagulogen-free clarified limulus amebocyte lysate (2025-07-15),

6. 12247188 - Cell culture chamber with improved cell-contacting surfaces (2025-03-11),

7. 12180511 - Automated production of viral vectors (2024-12-31),

8. 12163146 - Quality control methods for automated cell processing (2024-12-10),

9. 12037599 - Methods and constructs for production of lentiviral vector (2024-07-16),

10. 11906521 - Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen (2024-02-20),

11. 11827902 - End-to-end cell therapy automation (2023-11-28),

12. 11781113 - End-to-end cell therapy automation (2023-10-10),

13. 11773365 - Cell concentration methods and devices for use in automated bioreactors (2023-10-03),

14. 11718833 - Automated production of viral vectors (2023-08-08),

15. 11655481 - Methods for nuclear reprogramming using synthetic transcription factors (2023-05-23),

Company Overview

Lonza Walkersville, Inc. is a prominent player in the life sciences sector, specializing in the development and manufacturing of biologics and cell and gene therapies. The company focuses on providing innovative solutions that support the pharmaceutical and biotechnology industries. With a commitment to quality and scientific excellence, Lonza Walkersville plays a crucial role in advancing healthcare by enabling the production of complex biological products. Its operations are centered in Walkersville, Maryland, contributing to the broader life sciences ecosystem.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#1 in Walkersville, MD

#163 in Maryland

#12,875 in US

#24,848 in the World

Walkersville, MD, United States of America

Lonza Walkersville, Inc.

Forward Citations = 94

45 inventors:

Eytan Abraham (10 out of 18 patents)

Yaling Shi (7 out of 22 patents)

Erika McAfee (6 out of 6 patents)

4. Samatha Bandapalle (6 out of 6 patents)

5. Joseph O'Connor (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lonza Walkersville, Inc.. Retrieved from https://idiyas.com/company/lonza-walkersville

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…